Prognostic factors of unknown primary head and neck squamous cell carcinoma

Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
Chun-Chi HuangYuh-Shyang Chen

Abstract

To evaluate the prognostic factors of unknown primary head and neck squamous cell carcinoma (HNSCC). Retrospective study. Patients with unknown primary HNSCC from 1980 to 2000 were included. Forty-eight patients, predominantly male and with a mean age of 63.3+/-11.6 years, were recruited. The median survival time (MST) was 44 months. The overall survival rate was 60.4 percent at three years and 39.6 percent at five years. Forty-two patients receiving intervention regimens had a MST of 45 months, while six patients receiving palliative therapy had a MST of 8.5 months (log rank test, P=0.016). With multivariate Cox regression analysis, age (per year), higher nodal stage (N3 vs N1 or N2), and treatment (operation vs nonoperation) had a hazard ratio of 1.081 (P<0.0001), 5.852 (P=0.010), and 0.4 (P=0.042), respectively. Older age, higher nodal stage, and palliative treatment indicated poor prognosis. Survival time might be prolonged if surgical treatment is tolerable.

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·J R CosterL W DeSanto
Jan 1, 1995·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·A L OenP Knegt
Apr 1, 1996·The Journal of Laryngology and Otology·Y P TalmiC J Krause
Jul 1, 1997·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M J KirschnerR Sauer
Jan 14, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P Strojan, A Anicin
May 9, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C GrauB B Jensen
May 23, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H S ErkalS P Stringer
Apr 10, 2003·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Wolfgang J IssingStefan Tauber
Mar 17, 2004·Cancer Treatment Reviews·Barbara A Jereczek-FossaRoberto Orecchia
May 16, 2006·Acta Oto-laryngologica·Orlando Guntinas-LichiusRolf-Peter Mueller
Dec 19, 2007·Archives of Otolaryngology--head & Neck Surgery·Rajan S PatelChristopher J O'Brien

❮ Previous
Next ❯

Citations

Jun 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Nicholas PavlidisGeorge Plataniotis
Feb 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Laura CerezoAna Isabel Ballesteros
Oct 8, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·I TroussierJ Thariat
May 1, 2009·Head & Neck Oncology·Adeyi A AdogaTonga L Nimkur
Jan 30, 2019·Current Opinion in Otolaryngology & Head and Neck Surgery·Cesare PiazzaLorenzo Giannini
Oct 4, 2014·Molecular and Clinical Oncology·Shi Min ZhuangGe-Hua Zhang
Jun 12, 2017·Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale·Lars AxelssonEva Hammerlid

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
dissection
dissections

Software Mentioned

Excel
SAS

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.